Consequently, KMT2A rearrangement often failed to be identified as a risk factor in the analysis including all kinds of pediatric AML.21 A model built on the entire AML cohort may lose some accuracy in discriminating patients in one specific subtype. Here, KMT2A is linked to acute myeloid leukemia.